Latest Champions Biotechnlg (CSBR) Headlines Champions

New Post Public Reply Private Reply Replies (0) Message Board

Mar 9, 2014 at 12:10 PM

Latest Champions Biotechnlg (CSBR) Headlines

Champions Oncology Expands Oncology Data Processing Capabilities with Appointment of Ido Ben-Zvi, Ph.D., as Director of Bioinformatics and Machine Learning
PR Newswire - Tue Mar 04, 7:00AM CST
HACKENSACK, N.J., March 4, 2014 /PRNewswire/-- Champions Oncology, Inc. (OTC: CSBR), a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced the appointment of Ido Ben-Zvi, Ph.D., as Director of Bioinformatics and Machine Learning to exploit the company's wealth of oncology data from its TumorBank to support its Translational Oncology Solutions offerings for pharmaceutical companies.

Leading Regional Hospital Network in Asia to Offer Champions TumorGraft(TM) to Cancer Patients
PR Newswire - Wed Feb 26, 7:21AM CST
Champions Oncology (OTC: CSBR), a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced that a leading hospital network in Asia, Parkway Cancer Centre (PCC), will begin offering Champions TumorGrafts(TM) to cancer patients at its three facilities in Singapore and network locations throughout South East Asia.

Champions Oncology Names Angela Davies, M.D., Chief Medical Officer
PR Newswire - Mon Jan 06, 3:05PM CST
Champions Oncology (OTC: CSBR), a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced the appointment of Angela Davies, M.D., as Chief Medical Officer.

Champions Oncology Receives Accreditation From The Joint Commission
GlobeNewswire - Thu Jan 02, 3:00PM CST
Champions Oncology (OTC:CSBR), a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, announced today that its Baltimore, MD-based laboratory has received accreditation from The Joint Commission.

Champions Oncology Reports Results for the Quarter Ended October 31, 2013
GlobeNewswire - Thu Dec 12, 3:00PM CST
Champions Oncology, Inc. (OTC:CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, announced today its financial results for the fiscal quarter ended October 31, 2013.

Enrollment Commenced in Barnabas Health and Champions Oncology Breast Cancer Research Trial
GlobeNewswire - Tue Dec 10, 3:00PM CST
Champions Oncology (OTC:CSBR), a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, in conjunction with Barnabas Health, successfully enrolled the first patient in a groundbreaking breast cancer research trial.

FDA Nod for New Formulation of Teva's Treanda - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 18, 9:30AM CDT
Treanda, which was earlier available as an injection, will now be available in a liquid formulation as well.

Teva in Oncology Deals - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 17, 12:30PM CDT
Teva has been working on strengthening its oncology portfolio.

Champions Oncology Inc posts lower loss of USD0.77m for the three months ended 31 July 2013
M2 - Mon Sep 16, 5:56AM CDT
Oncology drug company Champions Oncology Inc (Other OTC:CSBR) stated on Friday its loss from operations of USD0.77m for the fiscal quarter ended 31 July 2013.

UPDATE -- Champions Oncology Reports Results for the Quarter Ended July 31, 2013
GlobeNewswire - Fri Sep 13, 8:24AM CDT
Champions Oncology, Inc. (OTC:CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, announced today its financial results for the fiscal quarter ended July 31, 2013.

Champions Oncology Reports Results for the Quarter Ended July 31, 2013
GlobeNewswire - Fri Sep 13, 5:30AM CDT
Champions Oncology, Inc. (OTC:CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, announced today its financial results for the fiscal quarter ended July 31, 2013.

Champions Oncology and Teva Sign a Discovery and Drug Development Partnership
GlobeNewswire - Thu Sep 12, 3:07PM CDT
Champions Oncology Inc. (OTC:CSBR) ("Champions"), a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced the signing of a new discovery and drug development partnership with Teva Pharmaceutical Industries LTD (NYSE:TEVA) which will utilize Champions TumorGraft(TM) technology platform to enhance and accelerate the clinical development of several of Teva's oncology compounds.

Champions Oncology Receives Regulatory Approval From New York State Department of Health
GlobeNewswire - Tue Sep 10, 10:45AM CDT
Champions Oncology (OTC:CSBR), a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, announced today that it has received a clinical laboratory permit from the New York State Department of Health to provide its innovative Champions TumorGraft test to patients in New York. This approval, coupled with the existing Clinical Laboratory Improvement Amendment ("CLIA") certification and other state approvals, enables Champions to offer its services without restrictions in 48 states. Champions TumorGraft test is the first and only in vivo sensitivity test approved and provides oncologists and patients with information that can predict the potential effect of a chemotherapeutic regimen on the patient's specific tumor.

Champions Oncology to Announce First Quarter Financial Results on Friday, September 13
GlobeNewswire - Mon Sep 09, 3:00PM CDT
Champions Oncology (OTC:CSBR), a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, announced today that it will announce its financial and operational results for the first quarter ended July 31, 2013 on Friday, September 13.

Champions Oncology to Present at the Rodman & Renshaw Annual Global Investment Conference
GlobeNewswire - Wed Sep 04, 6:00AM CDT
Champions Oncology (OTC:CSBR), a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, announced today that CEO, Joel Ackerman, will be presenting at Rodman & Renshaw's 15 Annual Global Investment Conference being held September 8-10 at the Millennium Broadway Hotel in New York, NY.

OtcbbJournal.com Initiates Coverage on ETAH, CSBR, AIVN and MTPR
Marketwire - Tue Sep 03, 7:01AM CDT
Eternity Healthcare, Inc. (OTCQB: ETAH) is a biopharmaceutical company with technologies in drug delivery, specialty pharmaceuticals and medical devices, currently focusing on the development of new subcutaneous formulation of otherwise intramuscular injectable drugs and needle-free injection systems. If you don't like needles, you need to see this report: http://bit.ly/ETAHREPORT

Champions Oncology Announces Two Additions to Senior Management Team
GlobeNewswire - Tue Sep 03, 6:00AM CDT
Champions Oncology (OTC:CSBR) announced today the addition of two members to its senior management team: Dr. Neal Goodwin, previously at Jackson Laboratory ("JAX"), was named Vice President of Corporate Research Development; and Jim McGorry, previously at Genzyme Corporation, was named Executive Vice President and General Manager of the Translational Oncology Solutions business. Both Goodwin and McGorry will be reporting to the CEO of the company.

OTC Daily Alert Stock Watch - Champions Oncology, Inc (OTCQB: CSBR)
WorldStockWire - Thu Aug 15, 10:30PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com

Champions Oncology to Host Fourth Quarter and Year-End Results Conference Call on June 10th
GlobeNewswire - Wed Jun 05, 3:00PM CDT
Champions Oncology, Inc. (OTC:CSBR) today announced that it will report its fourth quarter and year-end financial results after market close on Monday, June 10.

Champions Oncology to Exhibit and Present 6 Posters at the 2013 AACR Annual Meeting
GlobeNewswire - Thu Apr 04, 4:56PM CDT
Champions Oncology, Inc. (OTC:CSBR) is pleased to announce that it will be presenting six posters on its Champions TumorGraft(TM) models and Translational Oncology Solutions at the 2013 American Association of Cancer Research (AACR) Annual Meeting being held April 6 - 10 in Washington, DC. Champions will also be exhibiting at the event at Booth #1008.

Champions Oncology Inc. (CSBR) Stock Research Links

CSBR Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Palatin Prepares for FY27 Results Amid Market Curiosity

Mark Your Calendars, Investors! Folks grumble about the mundane task of checking fiscal calendars, but without this intel, where are we? On November 17, 2026, Palatin Technologies (NASDAQ:PTN) is slated to release their Q1 Fiscal Year 2027 operating results bright and early, before most of us have even sipped our coffee. The buzz around these numbers is as electric as any...

Walmart Tops 2026 Recall List: 81 Notices, Food Issues Lead

Walmart Behind 81 Recalls: Scrutinizing 2026's Top Contender For an outfit that prides itself on shaking up shopping carts coast to coast, Walmart's stumble onto the recall hotseat this year is a head-scratcher. Imagine leading with 81 official recalls—that's more than a flash in the pan, it's the whole frying pan catching fire. Target and Costco aren't slouches, but...

The Melt Expands with Key Texas Franchise Deal

Throwing Down the Gauntlet: The Melt Expands If there's one thing I've learned after decades watching these restaurant chains multiply like rabbits it’s this: when a veteran gets involved, you perk up. The Melt has done just that by roping in Syed Ahmad—a name that actually means something in this game—to open eight new locations in the Lone Star State. It isn't...

BETR Investors Face Action: Nov. 20 Deadline Nears

High Stakes for BETR Shareholders If you're holding shares in Better Home & Finance Holding Company, right now might feel like you're at a craps table with emptying pockets. BETR, trading under NASDAQ, has become the center of a legal hurricane, with investors eyeing the November 20th deadline to join a securities class action led by Hagens Berman. The class period in...

Fly-E Faces Revenue Drop Amid Retail Restructuring

Downturn Despite Strategic Restructuring Today, we're diving into Fly-E Group, Inc. (NASDAQ:FLYE) and the latest shakeup in their financials—spoiler alert, it's riding a downward slope. Quarter two of fiscal 2027 didn't exactly shine a light on profitability. Net revenues slid, dropping to $2.6 million this quarter, down from $3.9 million the previous year. Tack that up...

Data Center Transformers on the Brink of a Boom

A Flash Look: Powering Up Data Centers Look, if you're thinking of sidestepping data center transformers as just another cog in the machine, think again. This market's set to balloon—doubling from $5.59 billion in 2026 to a jaw-dropping $10.72 billion by 2031. We're talking a chunky 13.9% CAGR. Not every bit of news grabs you by the lapels, but this one does. What’s...

HiTHIUM Joins Cambridge to Boost Global Energy Storage

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

LEOTEK's AI Tech Shaping Smarter Cities at COP31

AI-Powered Evolution in Urban Infrastructure Hang on to your hats, folks, 'cause LEOTEK is turning heads at COP31 with its AI-driven transformation of urban landscapes. As cities stretch at the seams to keep up with modern challenges, LEOTEK's got more than a few tricks up its sleeve with its trademark blend of traffic system intelligence and energy management prowess....

YYForce Expands in UAE with Key Hospitality Wins

Unveiling YYForce's Middle East Strategy Smack in the middle of an aggressive Middle Eastern expansion, YYForce (NASDAQ: YFOR) is making waves with some new headline-grabbing contracts in the UAE. This ain't just a side hustle—it's big time. They're planting their flag across the luxury hospitality sector like they're going for a moon landing. The recent announcement...